Skip to main content

Epitalon vs Pinealon

Both Epitalon and Pinealon are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Epitalon

Evidence C+

Epitalon (Epithalon, AEDG)

A synthetic tetrapeptide that reportedly upregulates telomerase activity. Russian longevity studies suggest mortality reductions but Western RCTs are absent.

View full Epitalon profile →

Pinealon

Evidence C

Pinealon (EDR)

A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.

View full Pinealon profile →

Side-by-Side

AttributeEpitalonPinealon
Evidence GradeC+C
FDA StatusNot FDA-approved — Russian-origin research peptideNot FDA-approved — Russian-origin research peptide
Typical Dose5–10 mg daily for 10–20 days, cycled (subcutaneous)5–10 mg daily for 10–20 days (subcutaneous, cycled)
Clinics Indexed479
Categoriesanti-aging, longevitycognitive, longevity

Key reported benefits — Epitalon

  • Telomerase upregulation (preclinical)
  • Sleep/circadian normalization
  • Anti-aging signals

Key reported benefits — Pinealon

  • Cognitive function (preclinical)
  • Reduced oxidative damage
  • Sleep/circadian effects

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons